MedTrace Logo

Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia

NCT03232554 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2018-02-13

No results posted yet for this study

Summary

This study evaluates Buxue Yimu Pills，Ferrous Sulfate and the addition of Buxue Yimu Pills to Ferrous Sulfate in the treatment of Iron-Deficiency Anemia in adults women. One third of participanta will receive Buxue Yimu Pills, one third of participanta will receive Buxue Yimu Pills, one third of participanta will receive Ferrous Sulfate，and the another third will receive Buxue Yimu Pills and Ferrous Sulfate in combination.

Conditions

  • Iron-Deficiency Anemia

Interventions

DRUG

Buxue Yimu Pills

Buxue Yimu Pills 12g pill by mouth, twice daily.

DRUG

Buxue Yimu Pills &Ferrous Sulfate

Buxue Yimu Pills 12g pill by mouth, twice daily and Ferrous Sulfate 0.3g tablet by mouth, three times daily

DRUG

Ferrous Sulfate

Ferrous Sulfate 0.3g tablet by mouth, three times daily

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Aijun AJ Sun, MD · Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2018-12-31
Completion
2019-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03232554 on ClinicalTrials.gov